ASX not even bothered, such a soft market for tech sometimes.
- Forums
- ASX - By Stock
- EMV
- Ann: US Ethics Approval Received for Pivotal Validation Trial
EMV
emvision medical devices ltd
Add to My Watchlist
0.00%
!
$1.80

Ann: US Ethics Approval Received for Pivotal Validation Trial, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.80 |
Change
0.000(0.00%) |
Mkt cap ! $153.5M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1114 | $1.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.77 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1114 | 1.780 |
1 | 6620 | 1.760 |
1 | 490 | 1.730 |
1 | 293 | 1.720 |
2 | 3159 | 1.710 |
Price($) | Vol. | No. |
---|---|---|
1.770 | 1000 | 1 |
1.780 | 855 | 1 |
1.795 | 1249 | 1 |
1.800 | 4958 | 1 |
1.830 | 4500 | 1 |
Last trade - 08.50am 18/06/2025 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online